- The EU started legal action against the Anglo-Swedish pharma company last month.
- In a new court hearing on Wednesday, the EU asked for a financial compensation from AstraZeneca.
- The European Commission president said the bloc is on track to vaccinate 70% of its adult population by the end of July.
In this article
A medical worker prepares a syringe with AstraZeneca vaccine at a local community sports hall converted into a vaccination centre in Ventspils, Latvia.GINTS IVUSKANS | AFP | Getty Images
LONDON — A top EU official has dismissed the idea that Brussels could enter into new contract negotiations with AstraZeneca while a court is currently assessing whether the company breached its existing deal to supply coronavirus vaccines.
The European Union started legal action against the Anglo-Swedish pharma company last month over complaints that AstraZeneca failed to meet its delivery targets with the bloc. AstraZeneca has denied these accusations, saying it will strongly defend itself in court.
"For the moment, it's no," Didier Reynders, the EU commissioner for justice, told CNBC when asked whether the commission had plans for a new contract with AstraZeneca. "This is nonsense, to think about a new contract," he added.
